Persistent remission of acromegaly in a patient with GH‐secreting pituitary adenoma: Effect of treatment with pasireotide long‐acting release and consequence of treatment withdrawal-Reference-Cited by-同舟云学术

Persistent remission of acromegaly in a patient with GH‐secreting pituitary adenoma: Effect of treatment with pasireotide long‐acting release and consequence of treatment withdrawal

Published:2022-02-15 Issue:6 Volume:47 Page:835-840
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:Clinical Pharmacy Therapeu

Author:

Yu Na¹^ORCID,Wang Linjie¹,Yang Hongbo¹,Pan Hui¹,Duan Lian¹,Zhu Huijuan¹

Affiliation:

1. Key Laboratory of Endocrinology of National Health Commission Department of Endocrinology State Key Laboratory of Complex Severe and Rare Diseases Peking Union Medical College Hospital Chinese Academy of Medical Science and Peking Union Medical College Beijing China

Publisher

Hindawi Limited

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcpt.13615

Reference26 articles.

1. Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update

2. Acromegaly: An Endocrine Society Clinical Practice Guideline

3. Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority Study

4. Pasireotide for acromegaly: long-term outcomes from an extension to the Phase III PAOLA study

5. Efficacy and safety of long-acting pasireotide in patients with somatostatin-resistant acromegaly: a multicenter study

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term Remission in Functioning Pituitary Adenomas after Medical Therapy Withdrawal: A Chance for Cushing’s Disease;Endocrine, Metabolic & Immune Disorders - Drug Targets;2024-07-30

2. Comment on "Persistent remission of acromegaly in a patient with GH‐secreting pituitary adenoma: Effect of treatment with pasireotide long‐acting release and consequence of treatment withdrawal";Journal of Clinical Pharmacy and Therapeutics;2022-03-21